Skip to main content

MoneyWorks4Me

Cadila Healthcare informs about press release

23 Feb 2022 Evaluate

Cadila Healthcare has informed that it enclosed a copy of press release dated February 23, 2022 titled ‘Zydus receives final approval from USFDA for Dapagliflozin Tablets’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1906.40
Dr. Reddys Labs. 1377.25
Cipla 1399.00
Lupin 2006.40
Zydus Lifesciences 1205.00
View more..